We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$7.95B
AUM Growth
+$270M
Cap. Flow
+$103M
Cap. Flow %
1.29%
Top 10 Hldgs %
18.89%
Holding
388
New
10
Increased
185
Reduced
122
Closed
13

Top Sells

Rank Stock Value
1
MASI
Masimo
MASI
+$21.6M
2
ATR icon
AptarGroup
ATR
+$20.5M
3
LIN icon
Linde
LIN
+$17.6M
4
TCBI icon
Texas Capital Bancshares
TCBI
+$16.5M
5
EL icon
Estee Lauder
EL
+$16.4M

Sector Composition

Rank Sector Weight
1 Financials 17.58%
2 Technology 16.94%
3 Healthcare 14.62%
4 Industrials 13.62%
5 Consumer Discretionary 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDS icon
101
Factset
FDS
$9.35B
$23.5M 0.3%
96,705
+7,996
+9% +$2.22M
SEIC icon
102
SEI Investments
SEIC
$12.2B
$23.4M 0.29%
395,104
+28,283
+8% +$1.64M
LSTR icon
103
Landstar System
LSTR
$5.8B
$23.3M 0.29%
207,364
+1,740
+0.8% +$192K
JLL icon
104
Jones Lang LaSalle
JLL
$16.6B
$23M 0.29%
165,105
+46,567
+39% +$6.45M
MKC icon
105
McCormick & Company Non-Voting
MKC
$13.9B
$22.6M 0.28%
288,932
-4,492
-2% -$361K
NDSN icon
106
Nordson
NDSN
$16.3B
$22.6M 0.28%
154,348
+7,613
+5% +$1.06M
RPM icon
107
RPM International
RPM
$13.6B
$22.4M 0.28%
325,857
+23,661
+8% +$1.57M
AZPN
108
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$22.3M 0.28%
180,807
+14,785
+9% +$1.82M
BRKR icon
109
Bruker
BRKR
$9.53B
$22.1M 0.28%
502,968
-98,428
-16% -$4.41M
HON icon
110
Honeywell
HON
$76B
$21.8M 0.27%
136,393
-472
-0.3% -$75.1K
GMED icon
111
Globus Medical
GMED
$10.7B
$21.6M 0.27%
423,292
+118,336
+39% +$5.64M
FELE icon
112
Franklin Electric
FELE
$4.54B
$21.6M 0.27%
452,095
+1,103
+0.2% +$51.1K
WTS icon
113
Watts Water Technologies
WTS
$11.5B
$21.2M 0.27%
226,076
+975
+0.4% +$90.6K
CAKE icon
114
Cheesecake Factory
CAKE
$5.03B
$21M 0.26%
504,784
+36,394
+8% +$1.5M
FHB icon
115
First Hawaiian
FHB
$3.39B
$21M 0.26%
785,623
+37,106
+5% +$962K
CVX icon
116
Chevron
CVX
$384B
$20.9M 0.26%
176,328
-3,596
-2% -$437K
ANIK icon
117
Anika Therapeutics
ANIK
$239M
$20.4M 0.26%
371,596
+406
+0.1% +$20.8K
AKAM icon
118
Akamai
AKAM
$16.5B
$20.3M 0.25%
221,934
+17,788
+9% +$1.54M
STE icon
119
Steris
STE
$22.3B
$20.3M 0.25%
140,239
+10,146
+8% +$1.52M
MORN icon
120
Morningstar
MORN
$7.24B
$19.8M 0.25%
135,799
+662
+0.5% +$102K
FFIV icon
121
F5
FFIV
$22.5B
$19.8M 0.25%
141,288
+10,405
+8% +$1.44M
ACC
122
DELISTED
American Campus Communities, Inc.
ACC
$19.8M 0.25%
412,529
+14,963
+4% +$707K
HST icon
123
Host Hotels & Resorts
HST
$17.2B
$19.7M 0.25%
1,142,037
+931,357
+442% +$15.9M
HP icon
124
Helmerich & Payne
HP
$3.38B
$19.7M 0.25%
491,246
+264,437
+117% +$11.7M
COO icon
125
Cooper Companies
COO
$13.9B
$19.6M 0.25%
263,668
+21,764
+9% +$1.75M

Similar funds

Boston Trust Walden's Q3 2019 Portfolio in Review

As of Q3 2019, Boston Trust Walden held 388 positions worth $7.95B, up 3.5% from $7.68B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q3 2019 filing shows 10 new, 185 increased, 122 reduced and 13 closed positions. Its largest new stake was Analog Devices: 162,995 shares worth $18.2M. The largest sale was Masimo, an estimated $21.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Boston Trust Walden's largest Q3 2019 buy was Analog Devices: 162,995 shares worth $18.2M.
  • Boston Trust Walden added most to Verizon in Q3 2019, an estimated $44.1M increase.
  • Boston Trust Walden's biggest Q3 2019 reduction was Masimo, cutting an estimated $21.6M.
  • Boston Trust Walden fully exited Texas Capital Bancshares in Q3 2019, selling an estimated $16.5M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $7.95B portfolio in Q3 2019.
  • Boston Trust Walden opened 10 new positions and closed 13 in Q3 2019.
  • Boston Trust Walden's portfolio value rose 3.5% quarter-over-quarter to $7.95B.

Based on Boston Trust Walden's 13F filing for Q3 2019, filed 21 Oct 2019.